Persistent Tissue-Level Hypoperfusion (No-Reflow) Negates the Clinical Benefit of Successful Thrombectomy.
Journal: Stroke
Year: March 31, 2025
Neurologist
5
No OPD information available
Stroke
Transient Ischemic Attack (TIA)
Thrombectomy
Atrial Fibrillation
Carotid Artery Disease
Carotid Artery Surgery
Headache
Heart Attack
Helen M. Dewey is a female medical professional who specializes in helping patients who have had strokes, transient ischemic attacks (TIAs), heart attacks, and other related conditions. She is skilled in performing thrombectomy procedures, treating atrial fibrillation, carotid artery disease, and headaches.
Helen M. Dewey is known for her excellent communication with patients. She takes the time to listen to their concerns, explain medical information in a clear way, and involve them in decision-making about their treatment. Patients trust her because she shows empathy, respect, and genuine care for their well-being.
To stay up-to-date with the latest medical knowledge and research, Helen M. Dewey regularly attends conferences, reads medical journals, and participates in continuing education programs. This dedication ensures that she can provide the best and most effective treatments for her patients.
Helen M. Dewey works collaboratively with her colleagues and other medical professionals. She values teamwork, open communication, and mutual respect in her approach to patient care. By fostering positive relationships with her peers, she creates a supportive and efficient healthcare environment.
Through her work, Helen M. Dewey has made a positive impact on many patients' lives. Her expertise and compassionate care have helped patients recover from serious medical conditions, improve their quality of life, and regain their health and independence.
One of Helen M. Dewey's notable publications is "Persistent Tissue-Level Hypoperfusion (No-Reflow) Negates the Clinical Benefit of Successful Thrombectomy," published in Stroke. She has also been involved in clinical trials, such as the "A Multicentre, Randomised Controlled Trial of Exenatide Versus Standard Care in Acute Ischemic Stroke (TEXAIS)." These research efforts demonstrate her commitment to advancing medical knowledge and improving patient outcomes.
In summary, Helen M. Dewey is a dedicated and skilled healthcare professional who is committed to providing high-quality care, staying informed about the latest advancements in medicine, and making a positive difference in her patients' lives.
Journal: Stroke
Year: March 31, 2025
Enrollment Status: Unknown
Published: September 14, 2021
Intervention Type: Drug
Study Drug: Exenatide
Study Phase: Phase 2
Helen M. Dewey is an exceptional Neurologist who truly cares about her patients. She took the time to listen to my concerns and provided me with a clear treatment plan. Highly recommend!
Dr. Dewey is a knowledgeable and compassionate Neurologist. She explained my condition in a way that was easy to understand and made me feel at ease throughout the whole process.
I am so grateful for the care I received from Helen M. Dewey. She is a skilled Neurologist who goes above and beyond for her patients. I feel confident in her expertise and would trust her with my health any day.
Helen M. Dewey is a top-notch Neurologist in Heidelberg. She has a warm and friendly demeanor that instantly puts you at ease. I am extremely satisfied with the level of care I received from her.
Dr. Dewey is an outstanding Neurologist who is dedicated to helping her patients achieve optimal health. Her expertise and professionalism are truly commendable. I highly recommend her services.
I cannot thank Helen M. Dewey enough for the excellent care she provided as my Neurologist. She is not only highly skilled but also genuinely caring and attentive to her patients' needs. I am very impressed and satisfied with her services.